ArticlePloS one2023
Data-driven estimation of the instantaneous reproduction number and growth rates for the 2022 monkeypox outbreak in Europe.
Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Dynamics of global mpox epidemics, 1970-2025: a systematic review and meta-analysis of evolving transmissibility and intervention effects.BMJ global health · 2026Pooled it
- Decoding mpox: a systematic review and meta-analysis of the transmission and severity parameters of the 2022-2023 global outbreak.BMJ global health · 2025Pooled it
- Efficient sequential Bayesian inference for state-space epidemic models using ensemble data assimilation.PLoS computational biology · 2026Article
- Network structure induced bias in estimates of intrinsic generation times.PLoS computational biology · 2026Article
- Sensitivity analysis of epidemic forecasting and spreading on networks with probability generating functions.Journal of the Royal Society, Interface · 2026Article
- Mathematical modelling and time series clustering of Mpox outbreak: A comparative study of the top 10 affected countries and implications for future outbreak management.Global epidemiology · 2025Article
- Global transmission characteristics of mpox outbreaks: a systematic review and meta-analysis.EClinicalMedicine · 2025Article
- Modelling COVID-19 mutant dynamics: understanding the interplay between viral evolution and disease transmission dynamics.Royal Society open science · 2024Article
- Modeling spillover dynamics: understanding emerging pathogens of public health concern.Scientific reports · 2024Article
- Estimates of mpox effective reproduction number in Spain, April-August 2022.Epidemiology and infection · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo estimate the instantaneous reproduction number Rt and the epidemic growth rates for the 2022 monkeypox outbreaks in the European region.
methodsWe gathered daily laboratory-confirmed monkeypox cases in the most affected European countries from the beginning of the outbreak to September 23, 2022. A data-driven estimation of the instantaneous reproduction number is obtained using a novel filtering type Bayesian inference. A phenomenological growth model coupled with a Bayesian sequential approach to update forecasts over time is used to obtain time-dependent growth rates in several countries.
resultsThe instantaneous reproduction number Rt for the laboratory-confirmed monkeypox cases in Spain, France, Germany, the UK, the Netherlands, Portugal, and Italy. At the early phase of the outbreak, our estimation for Rt, which can be used as a proxy for the basic reproduction number R0, was 2.06 (95% CI 1.63 - 2.54) for Spain, 2.62 (95% CI 2.23 - 3.17) for France, 2.81 (95% CI 2.51 - 3.09) for Germany, 1.82 (95% CI 1.52 - 2.18) for the UK, 2.84 (95% CI 2.07 - 3.91) for the Netherlands, 1.13 (95% CI 0.99 - 1.32) for Portugal, 3.06 (95% CI 2.48 - 3.62) for Italy. Cumulative cases for these countries present subexponential rather than exponential growth dynamics.
conclusionsOur findings suggest that the current monkeypox outbreaks present limited transmission chains of human-to-human secondary infection so the possibility of a huge pandemic is very low. Confirmed monkeypox cases are decreasing significantly in the European region, the decline might be attributed to public health interventions and behavioral changes in the population due to increased risk perception. Nevertheless, further strategies toward elimination are essential to avoid the subsequent evolution of the monkeypox virus that can result in new outbreaks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.